When compared with men who remained robust or prefrail, those whose frailty status deteriorated over follow-up (n = 426; Supplemental Fig. 2) were older and had lower baseline BMI, but higher SHBG, LH, and FSH hormones and a higher prevalence of diabetes and CVD. The gene discussed is PLOD1; the disease is diabetes mellitus.